445 related articles for article (PubMed ID: 35669114)
21. A new acridone with antifungal properties against Candida spp. and dermatophytes, and antibiofilm activity against C. albicans.
de Oliveira DBC; Silva LB; da Silva BV; Borges TC; Marques BC; Dos Santos MB; de Oliveira LF; Bolzani VS; Rodrigues ARA; Regasini LO; Andrade AA
J Appl Microbiol; 2019 Nov; 127(5):1362-1372. PubMed ID: 31297951
[TBL] [Abstract][Full Text] [Related]
22. Repurposing the thrombopoietin receptor agonist eltrombopag as an anticryptococcal agent.
Ko HT; Hsu LH; Yang SY; Chen YL
Med Mycol; 2020 Jun; 58(4):493-504. PubMed ID: 31297540
[TBL] [Abstract][Full Text] [Related]
23. New Triazole NT-a9 Has Potent Antifungal Efficacy against Cryptococcus neoformans
Lu RY; Ni TJ; Wu J; Yan L; Lv QZ; Li LP; Zhang DZ; Jiang YY
Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31791946
[TBL] [Abstract][Full Text] [Related]
24. Unexplored antifungal activity of linear battacin lipopeptides against planktonic and mature biofilms of C. albicans.
De Zoysa GH; Glossop HD; Sarojini V
Eur J Med Chem; 2018 Feb; 146():344-353. PubMed ID: 29407961
[TBL] [Abstract][Full Text] [Related]
25.
Tetz G; Collins M; Vikina D; Tetz V
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30917977
[TBL] [Abstract][Full Text] [Related]
26. Antibiofilm and Antivirulence Activities of 6-Gingerol and 6-Shogaol Against
Lee JH; Kim YG; Choi P; Ham J; Park JG; Lee J
Front Cell Infect Microbiol; 2018; 8():299. PubMed ID: 30211127
[No Abstract] [Full Text] [Related]
27. An active domain SA-2 derived from cystatin-SA, and its antifungal activity.
Liu X; Huang X; Wang J; Zhang M; Liu M; Zhou C; Ma L
Amino Acids; 2023 Jan; 55(1):101-112. PubMed ID: 36333524
[TBL] [Abstract][Full Text] [Related]
28. Alexidine Dihydrochloride Has Broad-Spectrum Activities against Diverse Fungal Pathogens.
Mamouei Z; Alqarihi A; Singh S; Xu S; Mansour MK; Ibrahim AS; Uppuluri P
mSphere; 2018 Oct; 3(5):. PubMed ID: 30381356
[TBL] [Abstract][Full Text] [Related]
29. Chemical composition and biological activities of Artemisia judaica essential oil from southern desert of Jordan.
Abu-Darwish MS; Cabral C; Gonçalves MJ; Cavaleiro C; Cruz MT; Zulfiqar A; Khan IA; Efferth T; Salgueiro L
J Ethnopharmacol; 2016 Sep; 191():161-168. PubMed ID: 27318275
[TBL] [Abstract][Full Text] [Related]
30. Dracorhodin perchlorate inhibits biofilm formation and virulence factors of Candida albicans.
Yang LF; Liu X; Lv LL; Ma ZM; Feng XC; Ma TH
J Mycol Med; 2018 Mar; 28(1):36-44. PubMed ID: 29477784
[TBL] [Abstract][Full Text] [Related]
31. In vitro antifungal and antibiofilm activities of novel sulfonyl hydrazone derivatives against Candida spp.
Aydin M; Ozturk A; Duran T; Ozmen UO; Sumlu E; Ayan EB; Korucu EN
J Mycol Med; 2023 Mar; 33(1):101327. PubMed ID: 36272382
[TBL] [Abstract][Full Text] [Related]
32. Antifungal activity of peptide MSI-1 against Cryptococcus neoformans infection in vitro and in murine cryptococcal meningoencephalitis.
Ma L; Wei S; Ye X; Xu P; Chen H; Liu Z; Zhou C
Peptides; 2020 Aug; 130():170334. PubMed ID: 32504765
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of Biofilm Formation by
Lee JH; Kim YG; Khadke SK; Yamano A; Watanabe A; Lee J
ACS Infect Dis; 2019 Jul; 5(7):1177-1187. PubMed ID: 31055910
[No Abstract] [Full Text] [Related]
34. Evaluation of Antifungal Efficacy of Three New Cyclic Lipopeptides of the Class Bacillomycin from Bacillus subtilis RLID 12.1.
Ramachandran R; Shrivastava M; Narayanan NN; Thakur RL; Chakrabarti A; Roy U
Antimicrob Agents Chemother; 2018 Jan; 62(1):. PubMed ID: 29038271
[TBL] [Abstract][Full Text] [Related]
35. In vitro efficacy of eugenol in inhibiting single and mixed-biofilms of drug-resistant strains of Candida albicans and Streptococcus mutans.
Jafri H; Khan MSA; Ahmad I
Phytomedicine; 2019 Feb; 54():206-213. PubMed ID: 30668370
[TBL] [Abstract][Full Text] [Related]
36. In vitro and in vivo synergistic effects of hydroxychloroquine and itraconazole on Cryptococcus neoformans.
Wang X; Long X; Jia S; Zhu J; Zhou Z; Ahmed S; Jiang Y; Jiang Y
Folia Microbiol (Praha); 2023 Aug; 68(4):595-605. PubMed ID: 36753031
[TBL] [Abstract][Full Text] [Related]
37. Antifungal effects of alantolactone on Candida albicans: An in vitro study.
Yang L; Zhong L; Ma Z; Sui Y; Xie J; Liu X; Ma T
Biomed Pharmacother; 2022 May; 149():112814. PubMed ID: 35290888
[TBL] [Abstract][Full Text] [Related]
38. Susceptibility of Cryptococcus neoformans biofilms to antifungal agents in vitro.
Martinez LR; Casadevall A
Antimicrob Agents Chemother; 2006 Mar; 50(3):1021-33. PubMed ID: 16495265
[TBL] [Abstract][Full Text] [Related]
39. Polymeric micelles with anti-virulence activity against Candida albicans in a single- and dual-species biofilm.
Albayaty YN; Thomas N; Ramírez-García PD; Davis TP; Quinn JF; Whittaker MR; Prestidge CA
Drug Deliv Transl Res; 2021 Aug; 11(4):1586-1597. PubMed ID: 33713317
[TBL] [Abstract][Full Text] [Related]
40. Berberine Antifungal Activity in Fluconazole-Resistant Pathogenic Yeasts: Action Mechanism Evaluated by Flow Cytometry and Biofilm Growth Inhibition in Candida spp.
da Silva AR; de Andrade Neto JB; da Silva CR; Campos Rde S; Costa Silva RA; Freitas DD; do Nascimento FB; de Andrade LN; Sampaio LS; Grangeiro TB; Magalhães HI; Cavalcanti BC; de Moraes MO; Nobre Júnior HV
Antimicrob Agents Chemother; 2016 Jun; 60(6):3551-7. PubMed ID: 27021328
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
